10x Genomics to Report First Quarter Financial Results on May 11, 2020
April 24 2020 - 8:00AM
10x Genomics (Nasdaq: TXG) today announced it will report financial
results for the first quarter 2020 after market close on Monday,
May 11, 2020. The company’s management will webcast a corresponding
conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m.
Eastern Time to discuss its results, business developments and
outlook.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.10xgenomics.com. The webcast
will be archived and available for replay for at least 45 days
after the event.
About 10x Genomics
10x Genomics is a life science technology company building
products to interrogate, understand and master biology to advance
human health. The company’s integrated solutions include
instruments, consumables and software for analyzing biological
systems at a resolution and scale that matches the complexity of
biology. 10x Genomics products have been adopted by researchers
around the world including 96 of the top 100 global research
institutions and 19 of the top 20 global pharmaceutical companies,
and have been cited in over 700 research papers on discoveries
ranging from oncology to immunology and neuroscience. The company's
patent portfolio comprises more than 700 issued patents and patent
applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material nonpublic information and
for complying with its disclosure obligations under Regulation
FD.
Contacts
Investorsinvestors@10xgenomics.com
Mediamedia@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jul 2023 to Jul 2024